These results imply that PBCA nanoparticles facilitate the penetration of the large molecules across the barrier post trauma. In contrast, under normal conditions, it took 48 hours for PBCA nanoparticles to deliver a small amount of EGFP into the brain compared with 45 min after TBI.
The findings demonstrate three points: first, the successful entry via nanoparticles is not due to the BBB opening after TBI because the disrupted barrier limited the penetration of the HRP and EGFP alone; second, the particle-mediated penetration time is much shorter in the injured brain than that in the normal brain, so patients may benefit from the rapid delivery; third, PBCA nanoparticles may contribute to the increase of the therapeutic efficacy of medicine in TBI therapy since the particles can deliver more of these large molecules into the injured brain compared with those in the normal rat brain.
Full details can be found in the journal Nanotechnology.